France· FR:63894229
ICLUSIG 30 mg, comprimés pelliculés
A medicinal product containing chlorhydrate de ponatinib, registered in France by INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE PONATINIB
- Manufacturer
- INCYTE BIOSCIENCES DISTRIBUTION (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930047613flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)EUR 3.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de ponatinib in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIclusigTakeda Pharmaceuticals America, Inc.
- SwitzerlandIclusig
- CzechiaICLUSIGIncyte Biosciences Distribution B.V., Amsterdam
- SpainICLUSIG 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULAIncyte Biosciences Distribution B.V.
- FinlandIclusigIncyte Biosciences Distribution B.V.
- IrelandIclusig 30 mg film-coated tabletsIncyte Biosciences Distribution B.V.
- BelgiumIclusig 30 mgIncyte Biosciences Distribution
- NetherlandsIclusig 30 mg, filmomhulde tabletIncyte Biosciences Distribution B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Iclusig
- Liechtenstein · Iclusig
- Norway · Iclusig
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5c6fb1b3-a101-47d8-bb48-926541c424b2 GET /v1/drugs/5c6fb1b3-a101-47d8-bb48-926541c424b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63894229",
"date_amm": "2015-11-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/13/839",
"substance": "CHLORHYDRATE DE PONATINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de ponatinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.